Abstract | OBJECTIVES: METHOD: A multi-centre, masked, randomised study was conducted in cats presenting with clinical signs indicative of urinary tract infections. Cephalexin (Rilexine); Virbac) administered orally twice daily at 15 mg/kg bodyweight for 14 days was compared with a single subcutaneous injection of cefovecin in cats. The primary efficacy parameter assessed was bacterial elimination of the pretreatment uropathogen. RESULTS: CLINICAL SIGNIFICANCE:
|
Authors | C A Passmore, J Sherington, M R Stegemann |
Journal | The Journal of small animal practice
(J Small Anim Pract)
Vol. 49
Issue 6
Pg. 295-301
(Jun 2008)
ISSN: 0022-4510 [Print] England |
PMID | 18422501
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Cephalosporins
- cefovecin
|
Topics |
- Administration, Oral
- Animals
- Anti-Bacterial Agents
(therapeutic use)
- Cat Diseases
(drug therapy)
- Cats
- Cephalosporins
(therapeutic use)
- Double-Blind Method
- Escherichia coli Infections
(drug therapy, veterinary)
- Female
- Injections, Subcutaneous
(veterinary)
- Male
- Safety
- Treatment Outcome
- Urinary Tract Infections
(drug therapy, veterinary)
|